Retractable Technologies Profit Margin 2010-2024 | RVP
Current and historical gross margin, operating margin and net profit margin for Retractable Technologies (RVP) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Retractable Technologies net profit margin as of September 30, 2024 is -41.11%.
| Retractable Technologies Annual Profit Margins |
|---|
| Retractable Technologies Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.019B | $0.044B |
| Retractable Technologies, Inc. designs, develops, manufactures, and markets innovative patented safety needle devices for the healthcare industry. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $79.108B | 21.59 |
| Becton Dickinson (BDX) | United States | $64.745B | 17.02 |
| Cardinal Health (CAH) | United States | $29.487B | 15.99 |
| West Pharmaceutical Services (WST) | United States | $22.928B | 46.83 |
| Cooper (COO) | United States | $20.075B | 28.58 |
| Labcorp (LH) | United States | $20.046B | 16.62 |
| Align Technology (ALGN) | United States | $16.863B | 32.27 |
| Henry Schein (HSIC) | United States | $9.361B | 17.83 |
| Merit Medical Systems (MMSI) | United States | $6.139B | 31.35 |
| DENTSPLY SIRONA (XRAY) | United States | $3.731B | 10.15 |
| CONMED (CNMD) | United States | $2.314B | 19.31 |
| Patterson (PDCO) | United States | $1.803B | 9.52 |
| STAAR Surgical (STAA) | United States | $1.315B | 48.51 |
| Lifevantage (LFVN) | United States | $0.178B | 23.67 |
| Pro-Dex (PDEX) | United States | $0.152B | 30.36 |